Back to Search Start Over

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.

Authors :
Cavaleri M
Kaslow D
Boateng E
Chen WH
Chiu C
Choy RKM
Correa-Oliveira R
Durbin A
Egesa M
Gibani M
Kapulu M
Katindi M
Olotu A
Pongsuwan P
Simuyandi M
Speder B
Talaat KR
Weller C
Wills B
Baay M
Balasingam S
Olesen OF
Neels P
Source :
Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2024 Feb; Vol. 85, pp. 101745. Date of Electronic Publication: 2024 Feb 10.
Publication Year :
2024

Abstract

Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively, including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM ethics, environmental safety in CHIM, recruitment, community engagement, advertising and incentives, pre-existing immunity, and clinical, immunological, and microbiological endpoints. The fourth CHIM meeting focused on regulation of CHIM studies, bringing together scientists and regulators from high-, middle-, and low-income countries, to discuss barriers and hurdles in CHIM regulation. Valuable initiatives for regulation of CHIMs have already been undertaken but further capacity building remains essential. The Wellcome Considerations document is a good starting point for further discussions.<br /> (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1095-8320
Volume :
85
Database :
MEDLINE
Journal :
Biologicals : journal of the International Association of Biological Standardization
Publication Type :
Academic Journal
Accession number :
38341355
Full Text :
https://doi.org/10.1016/j.biologicals.2024.101745